Previous close | 8.16 |
Open | 8.35 |
Bid | 8.20 x 0 |
Ask | 8.49 x 0 |
Day's range | 8.26 - 8.46 |
52-week range | 5.70 - 10.16 |
Volume | |
Avg. volume | 2,084,669 |
Market cap | 3.778B |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.07 |
Earnings date | 29 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 15 Mar 2022 |
1y target est | 9.16 |
The Australian stock market has shown a steady rise over the past year, increasing by 9.1%, despite remaining flat in the last 7 days. In this context of expected earnings growth of 14% per annum in the coming years, identifying stocks that may be undervalued could present opportunities for investors looking for potential gains in a growing market.
Despite a slight downturn this week, the ASX200 has shown varied sector performance with notable movements in Health Care and Materials. As investors navigate these shifts, identifying stocks that appear undervalued relative to their intrinsic value could present opportunities for those looking to potentially enhance their portfolios amid current market conditions.
In the past year, the Australian stock market has shown modest growth with a 6.7% increase, while maintaining stability over the last week. Given these conditions and expected future earnings growth, stocks that are currently undervalued may present particularly appealing opportunities for investors looking for potential gains in a growing market.